Gregory B. Craven

This paper develops the first cell-active covalent inhibitors of RAB27-effector interactions, showing enantioselectivity and improved potency over a previously reported toxic compound.

The paper identifies benzoxaboroles as selective binders of eIF4E, revealing stereoselective interactions and structural insights into their binding mechanism.